KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cardinal Health (CAH) EBT (2016 - 2025)

Historic EBT for Cardinal Health (CAH) over the last 17 years, with Q4 2025 value amounting to $630.0 million.

  • Cardinal Health's EBT rose 2328.77% to $630.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 billion, marking a year-over-year increase of 2756.3%. This contributed to the annual value of $2.1 billion for FY2025, which is 7493.76% up from last year.
  • According to the latest figures from Q4 2025, Cardinal Health's EBT is $630.0 million, which was up 2328.77% from $598.0 million recorded in Q3 2025.
  • Over the past 5 years, Cardinal Health's EBT peaked at $665.0 million during Q1 2025, and registered a low of -$973.0 million during Q4 2021.
  • Its 5-year average for EBT is $251.0 million, with a median of $376.5 million in 2021.
  • Per our database at Business Quant, Cardinal Health's EBT tumbled by 32786.89% in 2021 and then soared by 132954.55% in 2024.
  • Quarter analysis of 5 years shows Cardinal Health's EBT stood at -$973.0 million in 2021, then skyrocketed by 89.31% to -$104.0 million in 2022, then surged by 592.31% to $512.0 million in 2023, then decreased by 0.2% to $511.0 million in 2024, then rose by 23.29% to $630.0 million in 2025.
  • Its EBT stands at $630.0 million for Q4 2025, versus $598.0 million for Q3 2025 and $384.0 million for Q2 2025.